This was followed by clinical expression and survival analyses, which validated eight genes (IGFBP3, CD72, SERPINH1, CHRDL2, LRP11, SPARCL1, DBI and HYAL1) as significant CRC candidates. Here, SPARCL1 is linked to colorectal carcinoma.